COAGUCHEK S SYSTEM 3116247

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 06 report with the FDA on 2006-05-24 for COAGUCHEK S SYSTEM 3116247 manufactured by Roche Diagnostics.

Event Text Entries

[458945] Discrepant results when compared to a lab. The reported device result was 7. 0 inr. The corresponding lab result reported was 3. 9 inr.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1823260-2006-02483
MDR Report Key719808
Report Source06
Date Received2006-05-24
Date of Report2006-05-11
Date of Event2006-05-10
Date Mfgr Received2006-05-11
Device Manufacturer Date2006-01-01
Date Added to Maude2006-05-31
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location0
Manufacturer ContactCHRISTOF LITTWITZ
Manufacturer Street9115 HAGUE ROAD
Manufacturer CityINDIANAPOLIS IN 46250
Manufacturer CountryUS
Manufacturer Postal46250
Manufacturer Phone3175212834
Manufacturer G1*
Manufacturer Street*
Manufacturer City*
Manufacturer Country*
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Details

Brand NameCOAGUCHEK S SYSTEM
Generic NamePROTHROMBIN TIME TEST STRIPS
Product CodeGJG
Date Received2006-05-24
Model NumberNA
Catalog Number3116247
Lot Number235A
ID NumberNA
Device Expiration Date2007-07-31
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Implant FlagN
Date RemovedA
Device Sequence No1
Device Event Key708876
ManufacturerROCHE DIAGNOSTICS
Manufacturer Address9115 HAGUE RD. INDIANAPOLIS IN 46250 US
Baseline Brand NameCOAGUCHEK PT TEST STRIPS
Baseline Generic NameCOAGUCHEK TEST STRIPS
Baseline Model NoNA
Baseline Catalog No3116247
Baseline IDNA
Baseline Device FamilyCOAGUCHEK
Baseline Shelf Life ContainedY
Baseline Shelf Life [Months]18
Baseline PMA FlagN
Baseline 510K PMNY
Premarket NotificationK974569
Baseline PreamendmentN
Baseline TransitionalN
510k ExemptN


Patients

Patient NumberTreatmentOutcomeDate
10 2006-05-24

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.